ERS 2022 Congress Highlights
Follow all the latest developments in RSV
The 2022 European Respiratory Society International Congress began on 4 September in Barcelona. With daily highlights covering RSV research, diagnosis and treatment, all the latest developments are simply a click away.
To get all the latest developments in RSV from ERS 2022 and listen to expert highlights, register for a free Medthority account today or log into your existing account.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
To get all the latest developments in RSV from ERS 2022, register for a free Medthority account today or log into your existing account
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
To get all the latest developments in RSV from ERS 2022, register for a free Medthority account today or log into your existing account
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
To get all the latest developments in RSV from ERS 2022, register for a free Medthority account today or log into your existing account
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
References
- Blasi F, Shi T, Miravitlles M. Understanding RSV: Identifying high risk adults. Presented at the European Respiratory Society International Congress 2022, 4 September. Barcelona. Industry Early Morning Symposium.
- Shi T. Understanding RSV: Burden of disease in high-risk adults. Presented at the European Respiratory Society International Congress 2022, 4 September. Barcelona. Industry Early Morning Symposium.
- Shi T, Denouel A, Tietjen AK, Campbell I, Moran E, Li X, et al. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Supplement_7):S577–S583.
- Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H. Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis. J Infect Dis. 2022;226(Suppl 1):S17-s21.
- Kim DK, McGeer A, Uleryk E, Coleman BL. Burden of severe illness associated with laboratory confirmed influenza in adults aged 50-64 years: A rapid review. Influenza Other Respir Viruses. 2022;16(4):632-642.
- Miravitlles M. RSV and chronic respiratory diseases: What are the consequences? Presented at the European Respiratory Society International Congress 2022, 4 September. Barcelona. Industry Early Morning Symposium.
- Willard A, Axelton T, Jain K. Respiratory syncytial virus (RSV) infection in children with neuromuscular diseases (NMD): a literature review & a survey of Palivizumab prophylaxis in the UK. Presented at the European Respiratory Society International Congress 2022, 5 September. Barcelona. Thematic poster.
- Axelson T, Willard A, Jain K1117 Survey of physician practice and opinions regarding the use of palivizumab as RSV prophylaxis, including in children with SMA Type 1. Archives of Disease in Childhood 2022;107:A246.
- Cunningham S, Roland D, Williams T. Features of an aseasonal 2021 RSV epidemic in the UK and Ireland: analysis of the first 10,000 patients. Presented at the European Respiratory Society International Congress 2022, 5 September. Barcelona. Thematic poster.
- Lyttle MD, O’Sullivan R, Hartshorn S, et al. Pediatric Emergency Research in the UK and Ireland (PERUKI): developing a collaborative for multicentre research. Arch. Dis. Child. 2014;99(6):602-603.
- Langedijk A. Late Breaking Abstract - Saliva as an alternative to nasopharyngeal swabs for detection of respiratory syncytial virus (RSV) in children. Presented at the European Respiratory Society International Congress 2022, 5 September. Barcelona. Oral Presentation.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
This content has been developed independently by EPG Health for Medthority and supported by a sponsorship grant from Janssen in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.